Abstract
Background
The Riata implantable cardioverter–defibrillator lead was recalled by the Food and Drug Administration because of an increased rate of failure associated with cable externalization. Because of its mechanical separation, the Riata lead may be challenging to extract. We therefore examined the experience with Riata lead extractions at our institution.
Methods
All patients implanted with the Riata lead underwent detailed review of their electronic medical records and operative notes. Procedural complications were ascertained by reviewing the medical records up to 30 days after Riata extraction.
Results
From a total of 627 patients implanted with the Riata lead at our institution, 20 patients (age at time of extraction, 57 ± 11 years; 85 % men; lead dwell time, 48 ± 27 months) underwent lead extraction. Extraction was successful in 19 of 20 (95 %) patients and required the use of laser-powered sheaths in 18 (90 %) patients. Over a 30-day follow-up period, 1 of 20 (5 %) patients had a minor procedure-related complication consisting of a new pericardial effusion that did not require drainage.
Conclusions
Extraction of the Riata lead seems to be successful and safe and frequently requires the use of powered sheaths.
Similar content being viewed by others
References
Cannom, D. S., & Prystowky, E. N. (2004). Evolution of the implantable cardioverter defibrillator. Journal of Cardiovascular Electrophysiology, 15, 375–385.
St. Jude Medical. (2002). St. Jude Medical announces FDA approval of the world's thinnest, most advanced defibrillation lead family [News Release]. Retrieved from http://investors.sjm.com/phoenix.zhtml?c=73836&p=irol-newsArticle&ID=278673&highlight=.
Israel, C. W., Duray, G. Z., Schmitt, J., & Hohnloser, S. H. (2008). Implantable cardioverter–defibrillator lead disintegration at the level of the tricuspid valve. Heart Rhythm, 5, 1224–1225.
Jalal, Z., Derval, N., Ploux, S., & Bordachar, P. (2010). Unusual failure of a multilumen, small-diameter implantable cardioverter–defibrillator lead. Heart Rhythm, 7, 1166–1167.
Hauser, R. G., Abdelhadi, R., McGriff, D., & Retel, L. K. (2012). Deaths caused by the failure of Riata and Riata ST implantable cardioverter–defibrillator leads. Heart Rhythm, 9, 1227–1235.
Parvathaneni, S. V., Ellis, C. R., & Rottmann, J. N. (2012). High prevalence of insulation failure with externalized cables in St. Jude Medical Riata family ICD leads: Fluoroscopic grading scale and correlation to extracted leads. Heart Rhythm, 9, 1218–1224.
US Food and Drug Administration (FDA). (2011). FDA classifies voluntary physician advisory letter on Riata and Riata ST silicone defibrillation leads as class I recall [Press Release]. Retrieved from http://www.fda.gov/Safety/Recalls/ucm283879.htm.
Wilkoff, B. L., Love, C. J., Byrd, C. L., Bongiorni, M. G., Carrillo, R. G., Crossley, G. H., 3rd, et al. (2009). Transvenous lead extraction: Heart Rhythm Society’s expert consensus on facilities, training, indications, and patient management. Heart Rhythm, 6, 1085–1104.
Kennergren, C., Bjurman, C., Wiklund, R., & Gabel, J. (2009). A single-centre experience of over one thousand lead extractions. Europace, 11, 612–617.
Jones, S. O., Eckart, R. E., Albert, C. M., & Epstein, L. M. (2008). Large, single-center, single-operator experience with transvenous lead extraction: Outcomes and changing indications. Heart Rhythm, 5, 520–525.
Maytin, M., Love, C. J., Fischer, A., Carrillo, R. G., Garisto, J. D., Bongiorni, M. G., et al. (2010). Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter–defibrillator lead. Journal of the American College of Cardiology, 56, 646–650.
Hauser, R. G., Kallinen, L. M., Almquist, A. K., Gornick, C. C., & Katsiyiannis, W. T. (2007). Early failure of a small-diameter high-voltage implantable cardioverter–defibrillator lead. Heart Rhythm, 4, 892–896.
Krahn, A. D., Champagne, J., Healey, J. S., Cameron, D., Simpson, C. S., Thibault, B., et al. (2008). Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: A report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm, 5, 639–642.
Gaca, J. G., Lima, B., Milano, A., Lin, S. S., Davis, R. D., Lowe, J. E., et al. (2009). Laser-assisted extraction of pacemaker and defibrillator leads: The role of the cardiac surgeon. The Annals of Thoracic Surgery, 87, 1446–1450.
Epstein, L. M., Byrd, C. L., Wilkoff, B. L., Love, C. J., Sellers, T. D., Hayes, D. L., et al. (1999). Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation, 100, 516–525.
Wilkoff, B. L., Byrd, C. L., Love, C. J., Hayes, D. L., Sellers, T. D., Schaerf, R., et al. (1999). Pacemaker lead extraction with the laser sheath: Results of the pacing lead extraction with the excimer sheath (Plexes) trial. Journal of the American College of Cardiology, 33, 1671–1676.
Epstein, A. E., Kay, G. N., Plumb, V. J., Dailey, S. M., & Anderson, P. G. (1998). Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation, 98, 1517–1524.
Kolodzinska, A., Kutarski, A., Koperski, L., Jarzyna, I., Małecka, B., & Opolski, G. (2012). Differences in encapsulating lead tissue in patients who underwent transvenous lead removal. Europace, 14, 994–1001.
Martin, D. T., Hook, B. G., Chaudhry, G. M., & Silver, J. (2011). Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter–defibrillator lead. Journal of the American College of Cardiology, 57, 635–636.
Acknowledgment
None.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patel, D., Adelstein, E., Nemec, J. et al. Extraction of defibrillator leads recalled for cable externalization and failure. J Interv Card Electrophysiol 36, 273–278 (2013). https://doi.org/10.1007/s10840-012-9751-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-012-9751-9